University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 16 of 26

COMPLETED Phase 4

Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?

NCT02861950

COMPLETED Phase 4

A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department

NCT03085563

COMPLETED NA

Strength Training to Improve Gait in People With Multiple Sclerosis

NCT03175133

COMPLETED Phase 1

A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001

NCT03126318

COMPLETED

Microbiome Insulin Sensitivity Study

NCT03120871

COMPLETED NA

Effects of Microbouts of Activity on Metabolic Health

NCT02998892

COMPLETED

Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease

NCT03081546

COMPLETED Phase 4

Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

NCT02940730

COMPLETED Phase 4

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)

NCT03073603

COMPLETED

Post-Prandial Liver Glucose Metabolism in PCOS

NCT03041129

TERMINATED NA

Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE

NCT03170869

COMPLETED NA

Asthma L-Citrulline Pilot Study

NCT02943161

COMPLETED NA

A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and Caregivers

NCT03016403

COMPLETED Phase 4

Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

NCT03090620

COMPLETED NA

Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia

NCT02875561

COMPLETED

Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics

NCT03092037

COMPLETED Phase 1

Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia

NCT03103009

COMPLETED NA

Brown Adipose Tissue Activity in Pre- and Postmenopausal Women

NCT02927392

COMPLETED

The Sleep in Pregnancy Study

NCT03248219

COMPLETED NA

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

NCT03076671

COMPLETED NA

State Immunization Information Systems to Improve HPV Vaccination Rates

NCT02993965

COMPLETED NA

Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma

NCT03783325

COMPLETED NA

Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation Support

NCT03065205

COMPLETED

The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

NCT02967055

COMPLETED

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

NCT03037671

COMPLETED

Self-reported Usage Patterns of Opioid Analgesic Medications After Surgery

NCT03034278

COMPLETED NA

Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans

NCT03077360

COMPLETED NA

CKDu in Sugarcane Workers in Guatemala

NCT03049527

COMPLETED

Evaluation of Moderate to Severe Influenza Outcomes in Children

NCT02979626

COMPLETED NA

Bicarbonate Administration in CKD

NCT02915601

COMPLETED Phase 3

Safety of Switching From Rituximab to Ocrelizumab in MS Patients

NCT02980042

COMPLETED NA

Training Educators to Conduct Functional Behavior Assessment Via Telehealth

NCT03079765

COMPLETED NA

Electrical Stimulus Therapy for Chronic Phantom Limb Pain

NCT03030079

COMPLETED Phase 4

Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes

NCT02502071

COMPLETED NA

The Multicenter Randomized HYpertension and VALUEs (HYVALUE) Trial

NCT03028597

COMPLETED NA

Mobilized Psychoeducation and Skills Based Intervention (Pep-Pal) for Caregivers of Patients With Advanced Illness

NCT03002896

TERMINATED NA

A Critical Illness Recovery Navigator for Alcohol

NCT03059082

TERMINATED

Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment

NCT04505735

COMPLETED Phase 1

A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

NCT02873598

COMPLETED NA

Alcohol, Inflammation, and Mindfulness Study (AIM)

NCT02994043

COMPLETED Phase 2

Feasibility Study of Metformin Therapy in ADPKD

NCT02903511

COMPLETED

Duration of Marijuana Concentration in Breast Milk- A Pilot Study

NCT02635568

COMPLETED Phase 4

Pulse Reduction On Beta-blocker and Ivabradine Therapy

NCT02973594

TERMINATED Phase 4

Treatment of Post-dural Puncture Headache in Postpartum Patients: Sphenopalatine Ganglion Block to Epidural Blood Patch.

NCT02962427

TERMINATED

Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?

NCT02567877

COMPLETED

Actigraphy in Pediatric Pulmonary Hypertension

NCT02909608

COMPLETED Phase 2

A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

NCT02818777

COMPLETED NA

Progressing Home Health Rehabilitation for Older Adults

NCT02905370

COMPLETED Early Phase 1

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

NCT02992015

COMPLETED NA

A Mindfulness Based Cognitive Therapy (MBCT) Resiliency Program for Critical Care Nurses

NCT03132220

← Previous Page 16 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.